Clinical Trial Update: Prognosis in Asymptomatic Mitral Regurgitation (PAMIR) Study

View source ↗

Summary

The PAMIR study, evaluating prognosis in asymptomatic mitral regurgitation, has completed its follow-up. No treatment details are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Mitral Regurgitation | Status: COMPLETED